ABIO Annual Retained Earnings
-$188.74 M
-$5.34 M-2.91%
31 December 2023
Summary:
As of February 5, 2025, ABIO annual retained earnings is -$188.74 million, with the most recent change of -$5.34 million (-2.91%) on December 31, 2023. During the last 3 years, it has fallen by -$34.59 million (-22.44%).ABIO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABIO Quarterly Retained Earnings
-$193.43 M
-$2.68 M-1.40%
30 June 2024
Summary:
As of February 5, 2025, ABIO quarterly retained earnings is -$193.43 million, with the most recent change of -$2.68 million (-1.40%) on June 30, 2024. Over the past year, it has dropped by -$4.69 million (-2.48%).ABIO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABIO Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.9% | -2.5% |
| 3 y3 years | -22.4% | -15.3% |
| 5 y5 years | -35.9% | -15.3% |
ABIO Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | +2201.7% | +1815.1% |
ARCA Biopharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | -$193.43 M(+1.4%) |
| Mar 2024 | - | -$190.75 M(+1.1%) |
| Dec 2023 | -$188.74 M(+2.9%) | -$188.74 M(+0.6%) |
| Sept 2023 | - | -$187.65 M(+0.8%) |
| June 2023 | - | -$186.23 M(+0.8%) |
| Mar 2023 | - | -$184.75 M(+0.7%) |
| Dec 2022 | -$183.40 M(+5.7%) | -$183.40 M(+0.6%) |
| Sept 2022 | - | -$182.23 M(+1.3%) |
| June 2022 | - | -$179.90 M(+1.8%) |
| Mar 2022 | - | -$176.75 M(+1.9%) |
| Dec 2021 | -$173.48 M(+12.5%) | -$173.48 M(+3.4%) |
| Sept 2021 | - | -$167.80 M(+2.9%) |
| June 2021 | - | -$163.09 M(+3.1%) |
| Mar 2021 | - | -$158.25 M(+2.7%) |
| Dec 2020 | -$154.15 M(+6.7%) | -$154.15 M(+3.4%) |
| Sept 2020 | - | -$149.03 M(+1.4%) |
| June 2020 | - | -$147.04 M(+0.9%) |
| Mar 2020 | - | -$145.74 M(+0.9%) |
| Dec 2019 | -$144.42 M(+3.9%) | -$144.42 M(+0.9%) |
| Sept 2019 | - | -$143.19 M(+0.8%) |
| June 2019 | - | -$142.03 M(+1.0%) |
| Mar 2019 | - | -$140.60 M(+1.2%) |
| Dec 2018 | -$138.93 M(+6.1%) | -$138.93 M(+1.1%) |
| Sept 2018 | - | -$137.44 M(+1.2%) |
| June 2018 | - | -$135.85 M(+1.6%) |
| Mar 2018 | - | -$133.74 M(+2.1%) |
| Dec 2017 | -$131.00 M(+16.4%) | -$131.00 M(+3.3%) |
| Sept 2017 | - | -$126.80 M(+3.6%) |
| June 2017 | - | -$122.37 M(+4.7%) |
| Mar 2017 | - | -$116.85 M(+3.9%) |
| Dec 2016 | -$112.51 M(+17.1%) | -$112.51 M(+3.9%) |
| Sept 2016 | - | -$108.27 M(+4.5%) |
| June 2016 | - | -$103.61 M(+3.9%) |
| Mar 2016 | - | -$99.71 M(+3.8%) |
| Dec 2015 | -$96.07 M(+13.5%) | -$96.07 M(+3.4%) |
| Sept 2015 | - | -$92.90 M(+3.1%) |
| June 2015 | - | -$90.08 M(+3.1%) |
| Mar 2015 | - | -$87.37 M(+3.2%) |
| Dec 2014 | -$84.62 M(+12.9%) | -$84.62 M(+3.2%) |
| Sept 2014 | - | -$82.01 M(+2.9%) |
| June 2014 | - | -$79.73 M(+3.1%) |
| Mar 2014 | - | -$77.32 M(+3.2%) |
| Dec 2013 | -$74.93 M(+10.2%) | -$74.93 M(+4.1%) |
| Sept 2013 | - | -$71.99 M(+2.5%) |
| June 2013 | - | -$70.26 M(+1.7%) |
| Mar 2013 | - | -$69.06 M(+1.6%) |
| Dec 2012 | -$67.99 M(+6.8%) | -$67.99 M(+1.3%) |
| Sept 2012 | - | -$67.15 M(+1.4%) |
| June 2012 | - | -$66.23 M(+1.8%) |
| Mar 2012 | - | -$65.08 M(+2.2%) |
| Dec 2011 | -$63.67 M(+9.2%) | -$63.67 M(+2.6%) |
| Sept 2011 | - | -$62.04 M(+3.0%) |
| June 2011 | - | -$60.22 M(-0.5%) |
| Mar 2011 | - | -$60.52 M(+3.8%) |
| Dec 2010 | -$58.31 M | -$58.31 M(+2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | -$56.72 M(+3.9%) |
| June 2010 | - | -$54.61 M(+4.3%) |
| Mar 2010 | - | -$52.34 M(+4.9%) |
| Dec 2009 | -$49.89 M(+22.4%) | -$49.89 M(+14.2%) |
| Sept 2009 | - | -$43.70 M(+10.9%) |
| June 2009 | - | -$39.40 M(+27.8%) |
| Mar 2009 | - | -$30.82 M(-24.4%) |
| Dec 2008 | -$40.75 M(-91.3%) | -$40.75 M(-91.8%) |
| Sept 2008 | - | -$497.67 M(+1.7%) |
| June 2008 | - | -$489.15 M(+0.0%) |
| Mar 2008 | - | -$488.92 M(+3.9%) |
| Dec 2007 | -$470.51 M(+2.7%) | -$470.51 M(+2.5%) |
| Sept 2007 | - | -$458.88 M(+3.2%) |
| June 2007 | - | -$444.52 M(-6.1%) |
| Mar 2007 | - | -$473.56 M(+3.3%) |
| Dec 2006 | -$458.21 M(+39.8%) | -$458.21 M(+16.6%) |
| Sept 2006 | - | -$392.88 M(+7.3%) |
| June 2006 | - | -$366.21 M(+5.4%) |
| Mar 2006 | - | -$347.31 M(+6.0%) |
| Dec 2005 | -$327.66 M(+28.0%) | -$327.66 M(+7.0%) |
| Sept 2005 | - | -$306.18 M(+6.4%) |
| June 2005 | - | -$287.72 M(+6.3%) |
| Mar 2005 | - | -$270.71 M(+5.7%) |
| Dec 2004 | -$256.05 M(+25.8%) | -$256.05 M(+5.3%) |
| Sept 2004 | - | -$243.07 M(+4.7%) |
| June 2004 | - | -$232.20 M(+5.0%) |
| Mar 2004 | - | -$221.24 M(+8.7%) |
| Dec 2003 | -$203.56 M(+32.7%) | -$203.56 M(+4.8%) |
| Sept 2003 | - | -$194.17 M(+6.0%) |
| June 2003 | - | -$183.26 M(+9.8%) |
| Mar 2003 | - | -$166.96 M(+8.9%) |
| Dec 2002 | -$153.37 M(+41.5%) | -$153.37 M(+12.1%) |
| Sept 2002 | - | -$136.86 M(+1.1%) |
| June 2002 | - | -$135.42 M(+6.3%) |
| Mar 2002 | - | -$127.35 M(+17.5%) |
| Dec 2001 | -$108.39 M(+50.7%) | -$108.39 M(+11.7%) |
| Sept 2001 | - | -$97.04 M(+11.5%) |
| June 2001 | - | -$87.03 M(+10.7%) |
| Mar 2001 | - | -$78.60 M(+9.3%) |
| Dec 2000 | -$71.92 M(+44.7%) | -$71.92 M(+10.3%) |
| Sept 2000 | - | -$65.23 M(+6.7%) |
| June 2000 | - | -$61.11 M(+9.1%) |
| Mar 2000 | - | -$56.00 M(+12.7%) |
| Dec 1999 | -$49.70 M(+59.8%) | -$49.70 M(+11.4%) |
| Sept 1999 | - | -$44.60 M(+10.7%) |
| June 1999 | - | -$40.30 M(+12.9%) |
| Mar 1999 | - | -$35.70 M(+14.8%) |
| Dec 1998 | -$31.10 M(+110.1%) | -$31.10 M(+16.0%) |
| Sept 1998 | - | -$26.80 M(+25.2%) |
| June 1998 | - | -$21.40 M(+23.0%) |
| Mar 1998 | - | -$17.40 M(+17.6%) |
| Dec 1997 | -$14.80 M(+80.5%) | -$14.80 M(+12.1%) |
| Sept 1997 | - | -$13.20 M(+14.8%) |
| June 1997 | - | -$11.50 M(+13.9%) |
| Mar 1997 | - | -$10.10 M |
| Dec 1996 | -$8.20 M | - |
FAQ
- What is ARCA biopharma annual retained earnings?
- What is the all time high annual retained earnings for ARCA biopharma?
- What is ARCA biopharma annual retained earnings year-on-year change?
- What is ARCA biopharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for ARCA biopharma?
- What is ARCA biopharma quarterly retained earnings year-on-year change?
What is ARCA biopharma annual retained earnings?
The current annual retained earnings of ABIO is -$188.74 M
What is the all time high annual retained earnings for ARCA biopharma?
ARCA biopharma all-time high annual retained earnings is -$8.20 M
What is ARCA biopharma annual retained earnings year-on-year change?
Over the past year, ABIO annual retained earnings has changed by -$5.34 M (-2.91%)
What is ARCA biopharma quarterly retained earnings?
The current quarterly retained earnings of ABIO is -$193.43 M
What is the all time high quarterly retained earnings for ARCA biopharma?
ARCA biopharma all-time high quarterly retained earnings is -$10.10 M
What is ARCA biopharma quarterly retained earnings year-on-year change?
Over the past year, ABIO quarterly retained earnings has changed by -$4.69 M (-2.48%)